Warren Wright

Directeur/Bestuurslid bij Bexson Biomedical, Inc.

Health Technology

Momenteel actieve connecties

Naam	Geslacht	Leeftijd	Verwante bedrijven	Samenwerking
Jeffrey Becker	M	-	Bexson Biomedical, Inc. Bexson Biomedical, Inc. BiotechnologyHealth Technology Bexson Biomedical, Inc. is a research stage company based in Santa Barbara, CA. The company is focused on developing BB106, a ketamine therapy for pain management and mental health disorders. The company is also applying their proprietary delivery platform to several psychedelic and non-psychedelic compounds to reduce suffering caused by pain, addiction, and mental health conditions. The company was founded by Jeffrey Becker and Gregg Peterson has been the CEO of the company since 2019.	-
Gregg Peterson	M	-	Bexson Biomedical, Inc. Bexson Biomedical, Inc. BiotechnologyHealth Technology Bexson Biomedical, Inc. is a research stage company based in Santa Barbara, CA. The company is focused on developing BB106, a ketamine therapy for pain management and mental health disorders. The company is also applying their proprietary delivery platform to several psychedelic and non-psychedelic compounds to reduce suffering caused by pain, addiction, and mental health conditions. The company was founded by Jeffrey Becker and Gregg Peterson has been the CEO of the company since 2019.	5 jaar
Belinda Tan	M	-	Bexson Biomedical, Inc. Bexson Biomedical, Inc. BiotechnologyHealth Technology Bexson Biomedical, Inc. is a research stage company based in Santa Barbara, CA. The company is focused on developing BB106, a ketamine therapy for pain management and mental health disorders. The company is also applying their proprietary delivery platform to several psychedelic and non-psychedelic compounds to reduce suffering caused by pain, addiction, and mental health conditions. The company was founded by Jeffrey Becker and Gregg Peterson has been the CEO of the company since 2019.	-
Itai Danovitch	M	-	Bexson Biomedical, Inc. Bexson Biomedical, Inc. BiotechnologyHealth Technology Bexson Biomedical, Inc. is a research stage company based in Santa Barbara, CA. The company is focused on developing BB106, a ketamine therapy for pain management and mental health disorders. The company is also applying their proprietary delivery platform to several psychedelic and non-psychedelic compounds to reduce suffering caused by pain, addiction, and mental health conditions. The company was founded by Jeffrey Becker and Gregg Peterson has been the CEO of the company since 2019.	-